Equities

Sinopharm Tech Holdings Ltd

Sinopharm Tech Holdings Ltd

Actions
Consumer DiscretionaryTravel and Leisure
  • Price (HKD)0.085
  • Today's Change0.00 / 0.00%
  • Shares traded21.00k
  • 1 Year change-47.85%
  • Beta1.8954
Data delayed at least 15 minutes, as of Sep 13 2024 06:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Jun 30 2023202320222021
ASSETS
Cash And Short Term Investments1.782.997.48
Total Receivables, Net234227
Total Inventory0.860.684.75
Prepaid expenses0.360.551.62
Other current assets, total1.131.449.23
Total current assets274850
Property, plant & equipment, net1.165.1928
Goodwill, net--012
Intangibles, net000.03
Long term investments5.272446
Note receivable - long term------
Other long term assets------
Total assets3377136
LIABILITIES
Accounts payable355542
Accrued expenses4.507.6115
Notes payable/short-term debt045100
Current portion long-term debt/capital leases00.934.15
Other current liabilities, total174142112
Total current liabilities213250273
Total long term debt003.58
Total debt046108
Deferred income tax0--0
Minority interest(7.02)(6.62)(1.68)
Other liabilities, total------
Total liabilities206244275
SHAREHOLDERS EQUITY
Common stock575755
Additional paid-in capital2,7042,7022,675
Retained earnings (accumulated deficit)(2942)(2942)(2882)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total7.781712
Total equity(173)(167)(139)
Total liabilities & shareholders' equity3377136
Total common shares outstanding184182176
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.